RsfA (YbeB) Proteins Are Conserved Ribosomal Silencing Factors

• Roman Häuser ,

  Contributed equally to this work with: Roman Häuser, Markus Pech, Jaroslaw Kijek, Hiroshi Yamamoto

  Affiliations Institute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Markus Pech ,

  Contributed equally to this work with: Roman Häuser, Markus Pech, Jaroslaw Kijek, Hiroshi Yamamoto

  Affiliations Abteilung Vingron, AG Ribosomen Max-Planck-Institut für Molekulare Genetik, Berlin, Germany, Institut für Medizinische Physik und Biophysik, Charité–Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Jaroslaw Kijek ,

  Contributed equally to this work with: Roman Häuser, Markus Pech, Jaroslaw Kijek, Hiroshi Yamamoto

  Affiliations Abteilung Vingron, AG Ribosomen Max-Planck-Institut für Molekulare Genetik, Berlin, Germany, Institut für Medizinische Physik und Biophysik, Charité–Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Hiroshi Yamamoto ,

  Contributed equally to this work with: Roman Häuser, Markus Pech, Jaroslaw Kijek, Hiroshi Yamamoto

  Affiliations Abteilung Vingron, AG Ribosomen Max-Planck-Institut für Molekulare Genetik, Berlin, Germany, Institut für Medizinische Physik und Biophysik, Charité–Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Björn Titz,

  Current address: Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California, United States of America

  Affiliation Institute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany

  ⨯
• Florian Naeve,

  Affiliation Institute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany

  ⨯
• Andrey Tovchigrechko,

  Affiliation J. Craig Venter Institute (JCVI), Rockville, Maryland, United States of America

  ⨯
• Kaori Yamamoto,

  Affiliations Abteilung Vingron, AG Ribosomen Max-Planck-Institut für Molekulare Genetik, Berlin, Germany, Institut für Medizinische Physik und Biophysik, Charité–Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Witold Szaflarski,

  Affiliations Abteilung Vingron, AG Ribosomen Max-Planck-Institut für Molekulare Genetik, Berlin, Germany, Department of Histology and Embryology, Poznan University of Medical Sciences, Poznan, Poland

  ⨯
• Nono Takeuchi,

  Affiliation Department of Medical Genome Sciences, Graduate School of Frontier Sciences, University of Tokyo, Kashiwa-shi, Chiba, Japan

  ⨯
• Thorsten Stellberger,

  Affiliation Institute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany

  ⨯
• Markus E. Diefenbacher,

  Affiliation Institute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany

  ⨯
• Knud H. Nierhaus ,

  * E-mail: nierhaus@molgen.mpg.de (KHN); peter@uetz.us (PU)

  Affiliations Abteilung Vingron, AG Ribosomen Max-Planck-Institut für Molekulare Genetik, Berlin, Germany, Institut für Medizinische Physik und Biophysik, Charité–Universitätsmedizin Berlin, Berlin, Germany

  ⨯
• Peter Uetz

  * E-mail: nierhaus@molgen.mpg.de (KHN); peter@uetz.us (PU)

  Affiliations Institute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany, Proteros Biostructures, Martinsried, Germany, Center for the Study of Biological Complexity, Virginia Commonwealth University, Richmond, Virginia, United States of America

  ⨯